CAR-T Therapy requires some medicines to be restricted, this guidance provides details and recommended wash-out periods for restricted medicines.


There are a number of restrictions in medicines allowed (and wash-out periods recommended) for patients on CAR-T Cell therapy at each stage of the pathway (apheresis, lymphodepletion, CAR-T infusion).


This guidance has been produced to document useful medication restriction information for CAR-T Cell therapy.


Update history

  1. Guidance reviewed and updated to version 5
  1. Published

Print this page